Clinical Trial Update: A Research Study to Compare Blood Levels of Cagrilintide and Semaglutide After Combined Versus Separate Injections in People With Overweight or Obesity [Phase 1]

View source ↗

Summary

A Phase 1 study comparing blood levels of cagrilintide and semaglutide after combined versus separate injections in adults with overweight or obesity has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• Cagrilintide (cagrilintide)
• semaglutide (semaglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Obesity & Overweight | Phase 1 | Status: COMPLETED